Unique Genetic Marker Could Better Detection of Recurrent Ovarian Cancer

Ovarian cancer is a cause of great anxiety to women’s health and the recognition of sensitive biomarkers for early discovery and/or monitoring of disease recurrence, is of high clinical significance.

New work published in the Dec. 7 issue of the online journal PLoS ONE reports promising advances toward the development of blood-based DNA markers for ovarian cancer.

Ovarian Cancer | Cancer in the Ovaries - Causes, Symptoms, Treatment & Prevention
Ovarian cancer affects both the ovaries and is referred to as the 'silent killer' as the symptoms go unnoticed until the disease advances.

The researchers, led by Peter W. Laird of the University of Southern California in Los Angeles, found that a DNA modification called "methylation" at a specific DNA site occurs frequently in ovarian tumors and can also be detected in the blood of ovarian cancer patients. This newly described methylation site was identified through a rigorous high-throughput screening process that tested over 27,000 different sites in the genome.

The epigenetic marker identified in this study was shown to have the potential to monitor disease status after surgery and might therefore prove helpful in enhancing the performance of existing biomarkers for disease recurrence.

Source-Eurekalert

About Cancer in Women
Cancer is one of the frequently talked about and most feared disease that falls under the genre of lifestyle diseases that have evolved, rather rapidly, in the past two decades.

Researchers Discover How Ovarian Tumors Elude The Immune System
In a new study, researchers at Johns Hopkins have uncovered how ovarian tumours allows the cancer to evade the body's immune system, causing the disease to spread without getting detected.

Ultrasound may Better Classify Ovarian Tumors
Experts examining patterns in ultrasound images can more accurately classify ovarian tumors as benign or malignant than can pre-surgical blood tests